The Role of Citicoline and Coenzyme Q10 in Retinal Pathology

Ocular neurodegenerative diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration are common retinal diseases responsible for most of the blindness causes in the working-age and elderly populations in developed countries. Many of the current treatments used in these path...

Descripción completa

Detalles Bibliográficos
Autores: García López, Claudia, García López, Verónica, Matamoros Felipe, José Antonio, Fernández Albarral, José, García Martín, Elena Salobrar, Hoz Montañana, María Rosa De, López Cuenca, Inés, Sánchez-Puebla Fernández, Lidia, Ramírez Sebastian, Jose Manuel, Ramírez Sebastián, Ana Isabel, Salazar Corral, Juan José
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/73089
Acceso en línea:https://hdl.handle.net/20.500.14352/73089
Access Level:acceso abierto
Palabra clave:616.9:617.7
617.7-004.681
617.735
Citicoline
Coenzyme Q10
CoQ10
Eye
Retina
Glaucoma
Non-arteritic ischemic optic neuropathy
Age-related macular degeneration
Diabetic retinopathy
Neurociencias (Medicina)
Oftalmología
Medicina
Óptica y optometría
2490 Neurociencias
3201.09 Oftalmología
2209 Óptica
Descripción
Sumario:Ocular neurodegenerative diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration are common retinal diseases responsible for most of the blindness causes in the working-age and elderly populations in developed countries. Many of the current treatments used in these pathologies fail to stop or slow the progression of the disease. Therefore, other types of treatments with neuroprotective characteristics may be necessary to allow a more satisfactory management of the disease. Citicoline and coenzyme Q10 are molecules that have neuroprotective, antioxidant, and anti-inflammatory properties, and their use could have a beneficial effect in ocular neurodegenerative pathologies. This review provides a compilation, mainly from the last 10 years, of the main studies that have been published on the use of these drugs in these neurodegenerative diseases of the retina, analyzing the usefulness of these drugs in these pathologies.